Bridge Biotherapeutics-capital increase
Bridge Biotherapeutics to raise 45.6 bln won via stock sale
SEOUL, May 23 (Yonhap) -- Bridge Biotherapeutics Inc.on Monday announced that it will sell stocks to raise 45.6 billion won (US$36.1 million). The proceeds from the stock offering will be used primarily to finance its operations.
According to a regulatory filing, the company will issue some 4.44 million preferred shares at a price of 10,250 won per share. The stocks will be sold to the investors that the firm designated.
(END)
(C) Yonhap News Agency. All Rights Reserved
